TY - JOUR
T1 - Peyer's patches play a protective role in nonsteroidal anti-inflammatory drug-induced enteropathy in mice
AU - Hiyama, Satoshi
AU - Iijima, Hideki
AU - Shinzaki, Shinichiro
AU - Inoue, Takahiro
AU - Shiraishi, Eri
AU - Kawai, Shoichiro
AU - Araki, Manabu
AU - Kato, Motohiko
AU - Hayashi, Yoshito
AU - Nishida, Tsutomu
AU - Fujii, Hironobu
AU - Mukai, Akira
AU - Shibata, Naoko
AU - Sato, Shintaro
AU - Kiyono, Hiroshi
AU - Gotoh, Kazuyoshi
AU - Motooka, Daisuke
AU - Nakamura, Shota
AU - Iida, Tetsuya
AU - Tsujii, Masahiko
AU - Takehara, Tetsuo
PY - 2014/5
Y1 - 2014/5
N2 - Background: Peyer's patches (PPs) play a major role in mucosal immunity. However, their roles in nonsteroidal anti-inflammatory drug-induced enteropathy are poorly understood. Methods: Wild-type (WT) and PP-null mice were injected with indomethacin. Twenty-four hours later, the cellular profiles and cytokine levels in the PPs, mesenteric lymph nodes (MLNs), and lamina propria (LP) of the small intestine were measured. WT and PP-null mice were given antibiotics before indomethacin treatment to evaluate enteropathy. Naive CD4+ T cells were co-cultured with CD103+ or CD103- dendritic cells (DCs) to analyze the interleukin (IL)-10 expression levels. Finally, WT mice adoptively transferred with CD103+ or CD103- DCs were injected with indomethacin. Results: The proportion of CD103+ DCs in PPs and MLNs and IL-10-expressing CD4+ T cells of PPs and the LP increased after indomethacin treatment. The PP-null mice showed greater indomethacin-induced enteropathy, fewer CD103+ DCs in their MLNs, and lower proportion of IL-10-expressing CD4+ T cells of their LP than WT mice, regardless of commensal bacteria. Naive splenic CD4+ T cells co-cultured with CD103+ DCs isolated from the MLNs of indomethacin-injected WT mice produced a higher amount of IL-10 compared with those co-cultured with CD103- DCs. Moreover, WT mice that received CD103+ DCs showed milder enteropathy than those that received CD103- DCs. Conclusions: PPs play a protective role in nonsteroidal anti-inflammatory drug-induced enteropathy, and this protection is associated with an increase in CD103+ DCs and IL-10-producing CD4+ T cells in the intestine, independent of the commensal bacteria.
AB - Background: Peyer's patches (PPs) play a major role in mucosal immunity. However, their roles in nonsteroidal anti-inflammatory drug-induced enteropathy are poorly understood. Methods: Wild-type (WT) and PP-null mice were injected with indomethacin. Twenty-four hours later, the cellular profiles and cytokine levels in the PPs, mesenteric lymph nodes (MLNs), and lamina propria (LP) of the small intestine were measured. WT and PP-null mice were given antibiotics before indomethacin treatment to evaluate enteropathy. Naive CD4+ T cells were co-cultured with CD103+ or CD103- dendritic cells (DCs) to analyze the interleukin (IL)-10 expression levels. Finally, WT mice adoptively transferred with CD103+ or CD103- DCs were injected with indomethacin. Results: The proportion of CD103+ DCs in PPs and MLNs and IL-10-expressing CD4+ T cells of PPs and the LP increased after indomethacin treatment. The PP-null mice showed greater indomethacin-induced enteropathy, fewer CD103+ DCs in their MLNs, and lower proportion of IL-10-expressing CD4+ T cells of their LP than WT mice, regardless of commensal bacteria. Naive splenic CD4+ T cells co-cultured with CD103+ DCs isolated from the MLNs of indomethacin-injected WT mice produced a higher amount of IL-10 compared with those co-cultured with CD103- DCs. Moreover, WT mice that received CD103+ DCs showed milder enteropathy than those that received CD103- DCs. Conclusions: PPs play a protective role in nonsteroidal anti-inflammatory drug-induced enteropathy, and this protection is associated with an increase in CD103+ DCs and IL-10-producing CD4+ T cells in the intestine, independent of the commensal bacteria.
KW - Mucosal immunity
KW - NSAID-induced enteropathy
UR - http://www.scopus.com/inward/record.url?scp=84902171827&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84902171827&partnerID=8YFLogxK
U2 - 10.1097/MIB.0000000000000017
DO - 10.1097/MIB.0000000000000017
M3 - Article
C2 - 24651581
AN - SCOPUS:84902171827
SN - 1078-0998
VL - 20
SP - 790
EP - 799
JO - Inflammatory Bowel Diseases
JF - Inflammatory Bowel Diseases
IS - 5
ER -